-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
More Companies Join Race To Ease US Baby Formula Supply Crunch
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC:DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said.
In February, Abbott Laboratories (NYSE:ABT) recalled dozens of Similac, Alimentum, and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.
Reuters reported that Reckitt Benckiser Group (OTC:RBGLY) said it is working "extremely closely" with the FDA to increase supply, including expediting the approval of some products made at a facility in Mexico.
Read Next: Abbott CEO Says 'We're Sorry About The Baby Formula Shortage,' Ensures Significant Investment For Future.
Reckitt, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture to expand the availability of formula under a program that helps low-income families.
"The Abbott recall affected 38 markets – it's not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.
Also See: Baby Formula From Europe Arrives In US: Enough For 9,000 Babies For A Week.
"Their focus is to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what that would entail."
Broseta said Danone is producing more formula in its Liverpool plant and not rerouting products from elsewhere.
"We will keep on serving our existing geographies at the level of their respective demand," she said.
Photo by Pexels from Pixabay
Danone SA (OTC:DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said.
達能公司(場外交易代碼:DANOY)一直在將對牛奶過敏的嬰兒配方奶粉對美國的發貨量增加一倍,而安福喜製造商利潔時該公司高管表示,在全國範圍內出現短缺的情況下,該公司還在努力增加供應。
In February, Abbott Laboratories (NYSE:ABT) recalled dozens of Similac, Alimentum, and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.
在2月份,雅培(紐約證券交易所股票代碼:ABT)召回數十種Similac、Alimentum和EleCare配方奶粉,造成美國家庭近期歷史上最緊迫的食品短缺之一。
Reuters reported that Reckitt Benckiser Group (OTC:RBGLY) said it is working "extremely closely" with the FDA to increase supply, including expediting the approval of some products made at a facility in Mexico.
據路透社報道,利潔時本基瑟集團(場外交易:RBGLY)表示,它正在與FDA“非常密切”地合作,以增加供應,包括加快批准在墨西哥的一家工廠生產的一些產品。
Read Next: Abbott CEO Says 'We're Sorry About The Baby Formula Shortage,' Ensures Significant Investment For Future.
接下來請閲讀:雅培首席執行官表示:“我們對嬰兒配方奶粉短缺深表歉意”,確保了未來的大量投資.
Reckitt, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture to expand the availability of formula under a program that helps low-income families.
利潔時表示,它還在與美國農業部合作,根據一項幫助低收入家庭的計劃,擴大嬰兒配方奶粉的供應。利潔時約佔美國嬰兒配方奶粉市場的一半。
"The Abbott recall affected 38 markets – it's not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.
“雅培的召回影響了38個市場--不僅僅是美國,”達能負責專業營養的副總裁Magdalena Broseta説。
Also See: Baby Formula From Europe Arrives In US: Enough For 9,000 Babies For A Week.
另請參閲:來自歐洲的嬰兒配方奶粉抵達美國:足夠9000名嬰兒吃一週.
"Their focus is to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what that would entail."
“他們的重點是打通其他玩家可能面臨的任何後勤問題,”她補充道。“現在説這將帶來什麼還為時過早。”
Broseta said Danone is producing more formula in its Liverpool plant and not rerouting products from elsewhere.
Broseta表示,達能正在其利物浦工廠生產更多配方奶粉,而不是從其他地方轉移產品。
"We will keep on serving our existing geographies at the level of their respective demand," she said.
她説:“我們將繼續為現有地區提供服務,滿足他們各自的需求。”
Photo by Pexels from Pixabay
圖片來源:PEXEL從…Pixabay
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧